ABSTRACT
Objective To observe the clinical efficacy of Xiezhuo Zhubi Decoction combined with Etoricoxib for the treatment of acute gout arthritis.Methods Seventy acute gout arthritis patients were randomly divided into treatment group and control group,35 cases in each group.Based on the fundamental treatment,the control group were given oral use of Etoricoxib and the treatment group was treated with Xiezhuo Zhubi Decoction combined with Etoricoxib.The treatment for both group lasted for 7 days.Before and after treatment,the changes of blood uric acid,C-reactive protein and erythrocyte sedimentation rate in both groups were observed.After treatment,the clinical efficacy was evaluated,and the toxic and adverse effects were also monitored.Results (1) In the treatment group,the total effective rate was 91.4％;in the control group,the total effective rate was 71.4％.There were significant differences between the two groups(P ＜ 0.05).(2) After treatment,blood uric acid,C-reactive protein and blood sedimentation rate were much improved in both groups (P ＜ 0.05 compared with those before treatment),and the treatment group had better effect on improving blood uric acid and C-reactive protein(P ＜ 0.05).(3) The control group had 3 cases of nausea,while no adverse reactions occurred in the treatment group.Conclusion Xiezhuo Zhubi Decoction combined with Etoricoxib is effective for the treatment of acute gout arthritis,and its effects on relieving clinical symptoms and decreasing blood uric acid and erythrocyte sedimentation rate are better than Etoricoxib alone.
ABSTRACT
Objective To observe the efficacy of lipoic acid combined with mosapride in the treatment of diabetic neurogenic bladder.Methods 30 patients with type 2 diabetes complicated with diabatic neurogenic bladder were treated with lipoic acid and mosapride for three weeks,on the base of good controlling of blood glucose,blood lipids,and other metabolic indicators.The residual urine volume of bladder and urodynamic indicators were compared before and after treatment.Results The residual urine volume of bladder and urodynamic indicators after treatment for three weeks and withdrawal for four weeks were (62.5 ± 27.8) ml and (61.3 ± 21.6) ml,(8.3 ± 1.9) ml/s and (7.9 ±2.1)ml/s,(10.7 ± 1.8)ml/s and (10.3 ± 1.6) ml/s,(25.6 ±2.7)cm H2O and (24.5 ±2.3)cm H2O,which were significiantly better than those before treatment [(128.3 ± 72.5) ml,(5.2 ± 1.3) ml/s,(8.4 ± 1.2) ml/s,(18.1 ±1.2)cm H2O](t=4.01,4.21,3.45,3.52,3.68,3.47,3.33,3.24,all P ＜0.01).Conclusion Lipoic acid combined with mosapride has good effect in the treatment of diabetic neurogenic bladder.
ABSTRACT
@#Objective To investigate the efficacy and safety of Escitalopram on panic disorder. Methods 40 patients were treated with Escitalopram. All patients were evaluated with Hamilton Anxiety Scale, Self-Rating Anxiety Scale and Adverse Drug Reactions Scale. Results All the patients released from panic since the second week after treatment, except one patient dropped because of side-effects. Other side-effects relieved during the course. Conclusion Escitalopram was effective and safe on panic disorder.
ABSTRACT
Computing the Nonlinear regressive (NLR) coefficients of electroencephalogram (EEG) rhythms at different brain cortical areas for the mental fatigue caused by long-term cognitive task, the variations of NLR coefficients of EEG rhythms under different mental fatigue level are sought out. The experimental results show that the NLR coefficients of EEG rhythms can effectively characterize the changes of amplitude coupling at different brain cortical areas under different mental fatigue level. The NLR coefficient provides a powerful tool for the EEG functional coupling analysis of mental fatigue.
Subject(s)
Adult , Humans , Male , Brain Mapping , Electroencephalography , Methods , Mental Fatigue , Nonlinear Dynamics , Signal Processing, Computer-AssistedABSTRACT
Firstly the fundamental concept and research hotspots of Brain-Neural Function Informatics (BNFI) are described. Then the main study fields and progresses of BNFI are expounded. Finally the prospects of BNFI research are given. Studies on BNFI not only promote the "Brain Science" progress, but also boost the industry of a new kind of medical instruments - function rehabilitation equipment and artificial functional prostheses.
Subject(s)
Animals , Humans , Biomedical Engineering , Brain , Physiology , Brain Diseases , Diagnosis , Rehabilitation , Computing Methodologies , Informatics , Methods , Nervous System Physiological PhenomenaABSTRACT
<p><b>BACKGROUND</b>5-dihydroxyanthraquinone-2-carboxylic acid (rhein) inhibits oxidoreduction induced by reducing nicotingamide adenine dinucleotide in the mitochondria and reducing reactive oxygen species, it also suppresses lipid peroxidation in rat brain homogenates. This study was to assess the effects of anthraquinone derivatives, rhein on synaptic transmission in the rat hippocampal CA1 pyramidal cell layer by intracellular recording.</p><p><b>METHODS</b>The excitatory postsynaptic potential (EPSP) evoked by stimulation of the Schaffer collaterals in the presence of bicuculline (15 micromol/L) was depressed by application of rhein (0.3 - 30 micromol/L). The amplitude of the EPSP was restored within 20 minutes after removal of rhein from the supernatant. At a concentration of 30 micromol/L, rhein reduced the amplitude of the EPSP to 42% +/- 3.7% (n = 24) of the control. Subsequently, wavelet spectral entropy was used to analyze the EPSP.</p><p><b>RESULTS</b>A strong positive correlation was observed between the wavelet spectral entropy and other parameters such as amplitude, slope of rising phase and slope of descending phase of the EPSP. The paired-pulse facilitation (PPF) of the EPSP was significantly increased by rhein (30 micromol/L). The inhibitory postsynaptic potential (IPSP) recorded in the presence of CNQX (20 micromol/L) and APV (40 micromol/L) is not altered by rhein (30 micromol/L).</p><p><b>CONCLUSIONS</b>Rhein (30 micromol/L) can decrease the frequency but not the amplitude of the miniature EPSP (mEPSP). It is suggested that rhein inhibits excitatory synaptic transmission by decreasing the release of glutamate in rat hippocampal CA1 pyramidal neurons.</p>
Subject(s)
Animals , Male , Rats , Anthraquinones , Chemistry , Pharmacology , Entropy , Excitatory Postsynaptic Potentials , Hippocampus , Physiology , In Vitro Techniques , Rats, Wistar , Synaptic TransmissionABSTRACT
Based on analyzing the problems of the existing medical monitoring systems and the clinical needs in medicine the main development aspects of modern medical monitoring techniques are discussed in the paper. Then the urgent needs of monitoring techniques are presented here.